SCHEMBL6953008

SCHEMBL6953008

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1NCC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.38
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 6/20 0.37
KMT2A Q03164 5/20 0.37
HPGD P15428 5/20 0.37
MEN1 O00255 4/20 0.37
HTT P42858 4/20 0.37
MAPT P10636 4/20 0.37
HSD17B10 Q99714 4/20 0.37
TP53 P04637 2/20 0.37
POLB P06746 3/20 0.35
TSHR P16473 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MAPK1 P28482 2/20 0.35
GAA P10253 1/20 0.35
HIF1A Q16665 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
RAB9A P51151 1/20 0.34
AKT1 P31749 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6955743 0.90 GRM2 (0.39) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6947580 0.85 HPGD (0.40) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6947600 0.83 GRM2 (0.40) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6950824 0.82 GRM2 (0.41) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6951385 0.79 GRM2 (0.40) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6952709 0.79 GRM2 (0.42) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6949302 0.79 GRM2 (0.43) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6953535 0.78 LIPE (0.38) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6949656 0.78 GRM2 (0.41) GRM2KDM4EALDH1A1KMT2AHPGD
SCHEMBL6951651 0.78 HPGD (0.43) GRM2KDM4EALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed